Guangdong Hengrui Pharmaceutical Co., Ltd

This large Phase 3 study is testing whether an injectable medication called SHR-1819 can safely reduce symptoms in adults with moderate to severe atopic dermatitis (eczema). Researchers are comparing the drug against a placebo in 652 participants to see if it significantly improv…

This is the first study in people to test a new drug called SHR-4712 for advanced solid tumors. The main goals are to find a safe dose and see how the body processes the drug. A small group of patients will receive the drug until side effects become too severe or their cancer get…